NNVC - NANOVIRICIDES, INC.
1.15
0.178 15.487%
Share volume: 946,033
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$0.97
0.18
0.18%
View ratios
| Fiscal Date | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q1 2026 | Q2 2026 | |
| Report Date | 02-14-2024 | 05-15-2024 | 01-07-2025 | 11-14-2024 | 02-14-2025 | 05-15-2025 | 11-14-2025 | 02-17-2026 | |
| Assets | |||||||||
| Total Assets | 13.402 M | 11.465 M | 12.823 M | 11.740 M | 11.571 M | 10.032 M | 8.357 M | 12.268 M | |
| Current Assets | 5.318 M | 3.516 M | 4.971 M | 4.041 M | 4.072 M | 2.727 M | 1.253 M | 5.297 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 5.245 M | 3.257 M | 4.798 M | 3.866 M | 3.958 M | 2.543 M | 1.126 M | 5.151 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 7.746 M | 7.603 M | 7.512 M | 7.366 M | 7.172 M | 6.983 M | 6.787 M | 6.656 M | |
| Other Assets | 338.302 K | 346.284 K | 339.870 K | 333.394 K | 326.919 K | 321.904 K | 317.058 K | 314.636 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 13.402 M | 11.465 M | 12.823 M | 11.740 M | 11.571 M | 10.032 M | 8.357 M | 12.268 M | |
| Total liabilities | 951.074 K | 813.337 K | 1.359 M | 1.633 M | 1.184 M | 1.199 M | 1.182 M | 1.196 M | |
| Total current liabilities | 951.074 K | 813.337 K | 1.359 M | 1.633 M | 1.184 M | 1.199 M | 1.182 M | 1.196 M | |
| Accounts Payable | 770.702 K | 554.542 K | 1.096 M | 1.349 M | 1.119 M | 1.166 M | 1.156 M | 1.148 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 12.451 M | 10.652 M | 11.464 M | 10.108 M | 10.387 M | 8.833 M | 7.175 M | 11.072 M | |
| Common stock | 147.616 M | 147.670 M | 150.839 M | 152.609 M | 154.916 M | 155.579 M | 157.802 M | 163.919 M | |
| Retained earnings | -135.164 M | -137.019 M | -139.375 M | -142.502 M | -144.529 M | -146.746 M | -150.627 M | -152.848 M |